Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142643 |
| CAS No | NA |
| Mol.F. | C16H21ClN4O3 |
| Mol.Wt. | 352.82 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142644 |
| CAS No | NA |
| Mol.F. | C14H17ClN4O3 |
| Mol.Wt. | 324.77 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142645 |
| CAS No | NA |
| Mol.F. | C16H22N4O4 |
| Mol.Wt. | 334.38 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142646 |
| CAS No | NA |
| Mol.F. | C15H18Cl2N4O4 |
| Mol.Wt. | 389.23 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142647 |
| CAS No | NA |
| Mol.F. | C14H10ClN3O5S |
| Mol.Wt. | 367.8 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142648 |
| CAS No | NA |
| Mol.F. | C14H9ClN2O3 |
| Mol.Wt. | 288.69 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142649 |
| CAS No | NA |
| Mol.F. | C16H14ClN3O5S |
| Mol.Wt. | 395.81 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142650 |
| CAS No | NA |
| Mol.F. | C14H10ClN3O4S |
| Mol.Wt. | 351.76 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142651 |
| CAS No | NA |
| Mol.F. | C28H18Cl2N4O9S2 |
| Mol.Wt. | 689.49 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142652 |
| CAS No | NA |
| Mol.F. | C14H8Cl2N2O3 |
| Mol.Wt. | 323.13 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142653 |
| CAS No | NA |
| Mol.F. | C17H16ClN3O5S |
| Mol.Wt. | 409.84 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142654 |
| CAS No | NA |
| Mol.F. | C15H12ClN3O5S |
| Mol.Wt. | 381.79 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142655 |
| CAS No | NA |
| Mol.F. | C14H8Cl2N2O4S |
| Mol.Wt. | 371.19 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142656 |
| CAS No | NA |
| Mol.F. | C14H11ClN4O4S |
| Mol.Wt. | 366.78 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142657 |
| CAS No | NA |
| Mol.F. | C14H8ClN3O5 |
| Mol.Wt. | 333.68 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142658 |
| CAS No | NA |
| Mol.F. | C7H7ClN4O6S2 |
| Mol.Wt. | 342.73 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |